Plasma cortisol and cortisone concentrations in normal subjects and patients with adrenocortical disorders

Metabolism: Clinical and Experimental

Volumn 53, Issue 1, 2004, Pages 89-94

  Morita, Hiroyuki ^a,b,c,d   Isomura, Yukinori ^a,b,c,d   Mune, Tomoatsu ^a,b,c,d   Daido, Hisashi ^a,b,c,d   Takami, Rieko ^a,b,c,d   Yamakita, Noriyoshi ^a,b,c,d   Ishizuka, Tatsuo ^a,b,c,d   Takeda, Noriyuki ^a,b,c,d   Yasuda, Keigo ^a,b,c,d   Gomez Sanchez, Celso E ^a,b,c,d  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Matsunami General Hospital   (Japan)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; CORTICOSTEROID; CORTISONE; DEXAMETHASONE; HYDROCORTISONE; ISOENZYME;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX INSUFFICIENCY; ADRENAL CORTEX TUMOR; ADULT; ARTICLE; CATHETERIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; CUSHING DISEASE; CUSHING SYNDROME; DRUG EFFECT; ENDOCRINE SURGERY; ENZYME ACTIVITY; FEMALE; FEMORAL VEIN; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERALDOSTERONISM; KIDNEY VEIN; LIVER VEIN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENOVASCULAR DISEASE;

EID: 9144223007     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.06.005     Document Type: Article

References (30)

1. Stewart PM, Krozowski ZS: 11 Beta-hydroxysteroid dehydrogenase. Vitam Horm 57:249-324, 1999
2. Krozowski Z, Li KX, Koyama K, et al: The type I and type II 11beta-hydroxysteroid dehydrogenase enzymes. J Steroid Biochem Mol Biol 69:391-401, 1999
3. Tannin GM, Agarwal AK, Monder C, et al: The human gene for 11 beta-hydroxysteroid dehydrogenase: Structure, tissue distribution, and chromosomal localization. J Biol Chem 266:16653-16658, 1991
4. Ricketts ML, Verhaeg JM, Bujalska I, et al: Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab 83:1325-1335, 1998
5. Hatakeyama H, Inaba S, Takeda R, et al: 11beta-hydroxysteroid dehydrogenase in human vascular cells. Kidney Int 57:1352-1357, 2000
6. Stewart PM, Whorwood CB, Mason JI: Type 2 11beta-hydroxysteroid dehydrogenase in foetal and adult life. J Steroid Biochem Mol Biol 55:465-471, 1995
7. Smith RE, Maguire JA, Stein-Oakley AN, et al: Localization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues. J Clin Endocrinol Metab 81:3244-3248, 1996
8. Suzuki T, Sasano H, Suzuki S, et al: 11Beta-hydroxysteroid dehydrogenase type 2 in human lung: Possible regulator of mineralocorticoid action. J Clin Endocrinol Metab 83:4022-4025, 1998
9. Condon J, Gosden C, Gardener D, et al: Expression of type 2 11beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J Clin Endocrinol Metab 83:4490-4497, 1998
10. Krozowski ZS, Funder JW: Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80:6056-6060, 1983
11. Arriza JL, Weinberger C, Cerelli G, et al: Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science 237:268-275, 1987
12. Stewart PM: Cortisol as a mineralocorticoid in human disease. J Steroid Biochem Mol Biol 69:403-408, 1999
13. Albiston AL, Obeyesekere VR, Smith RE, et al: Cloning and tissue distribution of the human 11beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105:R11-17, 1994
14. Gomez-Sanchez CE, Leon LM, Gomez-Sanchez EP: Biotin-hydrazide derivatives for the development of steroid enzyme-linked immunoassays. J Steroid Biochem Mol Biol 43:523-527, 1992
15. Tanabe A, Naruse M, Nishikawa T, et al: Autonomy of cortisol secretion in clinically silent adrenal incidentaloma. Horm Metab Res 33:444-450, 2001
16. Reincke M: Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29:43-56, 2000
17. Rossi R, Tauchmanova L, Luciano A, et al: Subclinical Cushing's syndrome in patients with adrenal incidentaloma: Clinical and biochemical features. J Clin Endocrinol Metab 85:1440-1448, 2000
18. Walker BR, Campbell JC, Fraser R, et al: Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol (Oxf) 37:483-492, 1992
19. Ghany M, Hoofnagle JH: Approch to the patient with liver disease, in Braunwald E, Hauser SL, Fauci AS, et al (eds): Harrison's Principles of Internal Medicine (ed 15). New York, NY, McGraw-Hill, 2001, pp 1707-1711
20. Stewart PM, Boulton A, Kumar S, et al: Cortisol metabolism in human obesity: Impaired cortisone→cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 84:1022-1027, 1999
21. Masuzaki H, Paterson J, Shinyama H, et al: A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170, 2001
22. Orth DN, Kovacs WJ: The adrenal cortex. in Wilson JD (ed): Williams Textbook of Endocrinology (ed 9). Philadelphia, PA, Saunders, 1998, pp 517-664
23. Agarwal AK, Mune T, Monder C, et al: Cloning of cDNA encoding an NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase in sheep kidney. Endocr Res 21:389-397, 1995
24. Morineau G, Boudi A, Barka A, et al: Radioimmunoassay of cortisone in serum, urine, and saliva to assess the status of the cortisol-cortisone shuttle. Clin Chem 43:1397-1407, 1997
25. Homma M, Tanaka A, Hino K, et al: Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure. Metabolism 50:801-804, 2001
26. Dotsch J, Dorr HG, Stalla GK, et al: Effect of glucocorticoid excess on the cortisol/cortisone ratio. Steroids 66:817-820, 2001
27. Mazzocchi G, Aragona F, Malendowicz LK, et al: Cortisol-secreting adrenal adenomas express 11beta-hydroxysteroid dehydrogenase type-2 gene yet possess low 11beta-HSD2 activity. J Investig Med 49:191-194, 2001
28. Mune T, Morita H, Suzuki T, et al: Role of local 11 beta-hydroxysteroid dehydrogenase type 2 expression in determining the phenotype of adrenal adenomas. J Clin Endocrinol Metab 88:864-870, 2003
29. Ulick S, Wang JZ, Blumenfeld JD, et al: Cortisol inactivation overload: A mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 74:963-967, 1992
30. Midorikawa S, Sanada H, Hashimoto S, et al: Analysis of cortisol secretion in hormonally inactive adrenocortical incidentalomas: Study of in vitro steroid secretion and immunohistochemical localization of steroidogenic enzymes. Endocr J 48:167-174, 2001